JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.2%
5Y CAGR+4.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.2%/yr
vs +6.1%/yr prior
5Y CAGR
+4.3%/yr
Consistent
Acceleration
-1.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $23.43B | +2.4% |
| 2024 | $22.87B | +3.3% |
| 2023 | $22.15B | +6.8% |
| 2022 | $20.74B | +6.7% |
| 2021 | $19.44B | +2.2% |
| 2020 | $19.03B | -6.2% |
| 2019 | $20.30B | +24.0% |
| 2018 | $16.37B | +28.0% |
| 2017 | $12.79B | +9.6% |
| 2016 | $11.67B | - |